Patent applications published 29 December 2010
Selected patent applications from the weekly European Patents Bulletin
- Use of epicatechin and derivatives and salts thereof for cardiac protection or ischaemic myocardium and to ameliorate adverse cardiac remodelling
The Regents of the University of California 2265114*
- Combinations of hydroxypyrion compounds and silver compounds
Janssen Pharmaceutica 2265115*
- Steroidal ligands and their use in gene switch modulation
Intrexon 2265116*
- Inhibitors of protein phosphatase-1 and uses thereof
Howard University 2265117*
- Aerosolised LFA-1 antagonists for use in localised treatment of immune related disorders
Sarcode 2262124*
- Topical LFA-1 antagonists for use in localised treatment of immune related disorders
Sarcode 2262125*
- Enhanced transmucosal compsns and dosage form
Cephalon 2265250*
- Pharmaceutical compsns having desirable bioavailability
Alcon Research 2265251*
- Ophthalmic preparation containing a pyridinol derivative
Marvel Lifesciences 2262252*
- Oral dosage form containing a pyridinol derivative
Marvel Lifesciences 2265253*
- Formulations of vitamin K analogues for topical use
Hana Biosciences 2265255*
- Dithiocarbamate metal chelates and methods of making and using thereof
University of Utah Research Foundation 2265256*
- Inhalation compsn containing aclidinium for treatment of chronic obstructive pulmonary disease
Almirall 2265257*
- Inhalation compsn containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
Almirall 2265258*
- Rapidly disintegrating oral compsn of tramadol
Cadila Healthcare 2265259*
- Solid dosage form for treating headaches
Paindure 2265260*
- Drug delivery systems comprising weakly basic drugs and organic acids
Eurand 2265261*
- Particles comprising polymers with thioester bonds
DSM IP Assets 2265262*
- Transdermal therapeutic system for administration of fentanyl or an analogue thereof
Acino 2265264*
- Treatment of inflammatory conditions and diseases with metal thiols
The Charlotte-Mecklenburg Hospital Authority 2265265*
- Vitamin D compounds and methods for reducing ocular hypertension (OHT)
Wisconsin Alumni Research Foundation 2265266*
- Compsns comprising N-halogenated or N,N-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
NovaBay Pharmaceuticals 2265267*
- Stable fixed dose topical formulation
Glenmark Pharmaceuticals 2265268*
- Selective subtype alpha 2 adrenergic agents and methods for use thereof
Allergan 2265269*
- 2-aminopyridine kinase inhibitors
OSI Pharmaceuticals 2265270*
- Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
Eli Lilly 2265271*
- Adaptive biochemical signatures
Ontherix 2265272*
- Hexahydrocyclopentyl[F] indazole sulphonamides and derivatives thereof as selective glucocorticoid receptor modulators
Merck Sharp & Dohme 2265273*
- Methotrexate adjuvants to reduce toxicity and methods for using the same
Tosk; The Regents of the University of California 2265274*
- Antiviral therapeutic agents
BioCryst Pharmaceuticals 2265275*
- Compsns and methods for inhibiting expression of EG5 and VEGF genes
Alnylam Pharmaceuticals 2265276*
- Preparation and use of a plant extract from Solanum glaucophyllum with an enriched content of 1,25-dixydroxy-vitamin D3 glycosides and quercetin glycosides
Herbonis 2265277*
- A compsn for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it
Seoul National University Industry Foundation 2265278*
- Use of the PAT nonapeptide in the treatment of autoimmune diseases
Cil Pharma 2265279*
- Preparation of a pharmaceutical compsn for increasing bone mineral density
NV Organon 2265280*
- Use of interleukin-1 conjugates in the treatment of diabetes
Cytos Biotechnology 2265281*
- Novel crustacean androgenic gland hormone
VIB VZW 2265282*
- Auristatin drug linker conjugates
Seattle Genetics 2265283*
- Replication-defective flavivirus vaccines and vaccine vectors
Sanofi Pasteur Biologics 2265284*
- Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
ALK-Abelló 2265285*
- Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
INSERM (Institut National de la Santé et de la Recherche Médicale) 2265286*
- Methods of treating chronic pain
Pfizer 2265287*
- Methods of treating inflammatory pain
Pfizer 2265288*
- Compsns and methods for tissue-specific RNAI delivery in vivo
Alnylam Pharmaceuticals 2265289*
- Oligomer-aryloxy-substituted propanamine conjugates
Nektar Therapeutics 2265290*
- Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration
The Board of Regents of the University of Texas System 2265291*
- Coating systems for the controlled delivery of hydrophilic bioactive agents
SurModics 2265293*